Ge Long Hui·2025-11-10 07:33Core Viewpoint - Jianyin International's report indicates that BeiGene's net profit for Q3 reached $125 million, surpassing market consensus estimates of $80 million, with product revenue growing 40% year-on-year to $1.395 billion, aligning closely with the bank's predictions [1] Revenue Forecast Adjustments - The bank has raised its total revenue forecast for BeiGene for FY2025 by 4%, and for FY2026 and FY2027 by 1% each, adjusting the figures to $5.4 billion, $6.6 billion, and $8.8 billion respectively [1] - Adjusted net income (non-GAAP) for FY2025 has been increased from $556 million to $984 million, for FY2026 from $860 million to $1 billion, and for FY2027 from $2.5 billion to $2.7 billion [1] Target Price and Rating - The target price for BeiGene has been raised from HKD 230 to HKD 234, with a rating of "Outperform" [1]